Skip to main content
Clinical Trials/DRKS00016164
DRKS00016164
Recruiting
Phase 2

Proton therapy of tumors of the head and neck area: Prospective recording of efficiency and side effects at standard clinical doses - Proto-R-H

niversitätsklinikum Dresden, Klinik für Strahlentherapie und Radioonkologie0 sites456 target enrollmentDecember 20, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
C01
Sponsor
niversitätsklinikum Dresden, Klinik für Strahlentherapie und Radioonkologie
Enrollment
456
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Dresden, Klinik für Strahlentherapie und Radioonkologie

Eligibility Criteria

Inclusion Criteria

  • Head and neck tumors: squamous cell carcinomas, adenocarcinomas, rare histologies
  • \- Age \> 18 years
  • \- ECOG \< 2
  • \- Indication for high\-dose primary radiotherapy or radiochemotherapy or for high\-dose adjuvant radiotherapy or radiochemotherapy
  • \- Treatment (radiation dose, additional systemic therapies) according to current clinical standard possible and planned
  • \- Ability to consent and the patient's present written consent

Exclusion Criteria

  • \- Lack of possibility of MRI planning (e.g. contraindications to performing an MRI)
  • \- Lack of patient compliance
  • \- Missing or limited possibility of reproducible positioning (e.g. due to severe limitation of patient mobility)
  • \- metals in the region to be irradiated (e.g. internal fixator in the affected section of the cervical spine) if they interfere with dose distribution
  • \- Tumors of the skull base or with irradiation area that reaches the skull base in large volume (\-\-\> include in Proto\-R skull base)

Outcomes

Primary Outcomes

Not specified

Similar Trials